|
Petersen, Gloria M. |
Mayo Clinic Rochester |
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer |
Pancreatic Cancer Detection Consortium |
PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units |
|
Hollingsworth, Michael A. |
University Of Nebraska Medical Center |
Pancreatic Cancer Detection Consortium |
Pancreatic Cancer Detection Consortium |
PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units |
|
Goggins, Michael G. |
Johns Hopkins University |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
Pancreatic Cancer Detection Consortium |
PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units |
|
Wolpin, Brian Matthew |
Dana-Farber Cancer Inst |
Altered metabolism and machine learning for pancreatic cancer early detection |
Pancreatic Cancer Detection Consortium |
PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units |
|
Oberg, Ann Laura |
Mayo Clinic Rochester |
Management and Data Coordination Unit for PCDC |
Pancreatic Cancer Detection Consortium |
PAR-21-335: Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit |
|
Zhang, Zhen |
Johns Hopkins University |
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer |
Early Detection Research Network, EDRN Biomarker Development Lab |
RFA-CA-14-014: The Early Detection Research Network: Biomarker Developmental Laboratories |
|
Showe, Louise C. |
Wistar Institute |
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer |
Early Detection Research Network, EDRN Biomarker Development Lab |
RFA-CA-14-014: The Early Detection Research Network: Biomarker Developmental Laboratories |
|
Haab, Brian B. |
Van Andel Research Institute |
Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers |
Early Detection Research Network, EDRN Biomarker Development Lab |
RFA-CA-14-014: The Early Detection Research Network: Biomarker Developmental Laboratories |
|
Zhang, Hui |
Johns Hopkins University |
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer |
Early Detection Research Network, EDRN Biomarker Development Lab |
RFA-CA-14-014: The Early Detection Research Network: Biomarker Developmental Laboratories |
|
Schabath, Matthew B |
H. Lee Moffitt Cancer Ctr & Res Inst |
Moffitt Imaging Biomarker VAlidation Center |
Early Detection Research Network, EDRN Clinical Validation Center |
RFA-CA-14-015: The Early Detection Research Network: Clinical Validation Centers |
|
Bast, Robert C |
University Of Tx Md Anderson Can Ctr |
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer |
Early Detection Research Network, EDRN Clinical Validation Center |
RFA-CA-14-015: The Early Detection Research Network: Clinical Validation Centers |
|
Chan, Daniel Wanyui |
Johns Hopkins University |
Clinical and Analytical Validation of Cancer Biomarkers |
Early Detection Research Network, EDRN Biomarker Reference Lab |
RFA-CA-14-016: The Early Detection Research Network: Biomarker Reference Laboratories |
|
Almonte, Maribel |
International Agency For Res On Cancer |
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries |
|
RFA-CA-15-001: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3) |
|
Grady, William Mallory |
Fred Hutchinson Cancer Center |
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states. |
|
RFA-CA-15-008: Research Answers to NCI's Provocative Questions |
|
Riegel, Anna Tate |
Georgetown University |
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer |
|
RFA-CA-15-008: Research Answers to NCI's Provocative Questions |
